The Research & Development to Sales ratio is a measure to compare the effectiveness of R&D expenditures between companies in the same industry. It is calculated as R&D expenditure divided by Total Sales. This is measured on a TTM basis.
This is calculated by dividing the Research & Development Expense by total sales or revenue.
R&D expense is not always broken out in a company's financials, however, so this value may be n/a in those cases.
Comparisons are not always useful across industries - for example, pharmaceuticals and software companies tend to spend a lot on R&D while consumer product companies spent less.
This is measured on a TTM basis.
| Ticker | Name | R&D / Sales | StockRank™ |
|---|---|---|---|
| LON:PRTC | Puretech Health | 17,525.00% | 13 |
| LON:KAV | Kavango Resources | 939.71% | 5 |
| LON:4BB | 4Basebio | 710.23% | 4 |
| LON:MATD | Petro Matad | 692.63% | 12 |
| LON:OBI | Ondine Biomedical | 382.86% | 11 |